Among all sequenced iridoviruses, VP19 and its orthologues shared common features, including 19 invariant cysteines, a proline-rich motif and a predicted transmembrane domain

Among all sequenced iridoviruses, VP19 and its orthologues shared common features, including 19 invariant cysteines, a proline-rich motif and a predicted transmembrane domain. common features, including 19 invariant cysteines, a proline-rich motif and a predicted transmembrane domain name. Subsequently, the protein synthesis of VP19 was only detected at the late stage of SGIV contamination and inhibited obviously by treating with AraC, confirming that VP19 was a late expressed protein. Ectopic expression of EGFP-VP19 displayed a punctate pattern in the cytoplasm. In SGIV infected cells, the newly synthesized VP19 protein was initially localized in the cytoplasm in a punctate pattern, and then aggregated into the computer virus assembly site at the late stage of SGIV contamination, suggesting that other viral protein products were essential for VP19s function during SGIV contamination. In addition, Western blot assay and electron microscopy observation revealed that SGIV VP19 was associated with viral envelope, which was different from major capsid protein (MCP). Conclusion Taken together, the current data suggested that VP19 represented a conserved envelope protein in iridovirus, and might contribute greatly to computer virus assembly during computer virus contamination. was subdivided into five genera, including and was isolated from your diseased grouper [3]. SGIV contamination evoked enlarged spleen with haemorrhage in BL21 and induced by IPTG. As shown in Physique?2A, the recombinant fusion protein was observed in the supernatant of pET-VP19t after induction, but not in un-induced product. After purification, a single band at approximately 45 kD (fusion protein contained VP19t and His tag) was acquired and used to prepare anti-VP19 polyclonal antibody. The specificity of anti-VP19 antibody was examined using the lysates from mock-infected and SGIV infected GS cells at 24?h p.i. The results showed that this anti-VP19 antibody acknowledged the synthesized VP19 protein with molecular excess weight of 37 c-Kit-IN-2 kD, while no protein band was detected in the mock-infected cell lysate (Physique?2B). In addition, no protein band Mouse monoclonal to p53 was detected in the SGIV infected cell lysate when unfavorable control serum c-Kit-IN-2 was used as the primary antibody (data not shown). Open in a separate window Physique 2 Expression dynamics of SGIV VP19. (A) SDS-PAGE analysis of purified recombinant SGIV VP19. Lines M, 1, 2, 3, 4 and 5 showed protein markers, pET-VP19 (uninduced), pET-VP19 (IPTG induced), supernatant, pellet of induced pET-VP19 and the purified pET-VP19, respectively. (B) The specificity of anti-VP19 serum. SGIV or mock infected cells at 48?h p.i. were collected and centrifuged for SDS-PAGE and western blotting. Collection M, 1 and 2 showed protein markers, mock and SGIV infected cells c-Kit-IN-2 at 48?h p.i., respectively. (C) The expression pattern of VP19 during SGIV contamination. Actin was chosen as the internal control. (D) VP19 was identified as a late protein. Cells were infected with SGIV at MOI of 0.5 for 6?h and 24?h under the treatment with CHX or AraC, respectively. Then cells were collected for western blotting analysis. The late protein MCP was chosen as a positive control. To characterize the expression pattern of VP19 during SGIV contamination, the protein synthesis level of VP19 at different time points were detected by western blotting. As shown in Physique?2C, VP19 specific protein band of ~37 kD was obviously c-Kit-IN-2 detected from 24?h p.i., and its expression increased up to 48?h p.i. as well as the MCP specific band (~49 kD). As an internal control, the protein expression remained no obvious changes throughout SGIV contamination. Further analysis using inhibitor assay showed that both VP19 and major capsid protein (MCP) expression could be significantly inhibited by the addition of AraC (Physique?2D), suggesting that VP19 was a late gene during SGIV contamination. VP19 was localized in cytoplasm after transfection To clarify the localization of VP19 in filamentous computer virus 1 (AFV1) [30]. Using this method, we found that VP19 was only present in the envelope portion, but not in the capsid portion. Moreover, the reported envelope protein VP88 and capsid protein VP38 were also verified via treating with 0.1% SDS (unpublished data). Much like VP19, another iridovirus core envelope protein RGV 53R has been reported to c-Kit-IN-2 be associated with computer virus factory and involved in virion assembly [10,32]. In addition, immuno-electron microscopy studies showed that platinum particles conjugated with anti-VP19 were only distributed on the surface of the computer virus envelope, while those conjugated with anti-MCP were only.